Fjarde Ap-fonden’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-27,000
Closed -$2.01M 573
2021
Q1
$2.01M Buy
27,000
+600
+2% +$44.7K 0.02% 550
2020
Q4
$4.5M Buy
26,400
+400
+2% +$68.2K 0.04% 411
2020
Q3
$3.65M Buy
26,000
+2,300
+10% +$323K 0.04% 433
2020
Q2
$3.8M Sell
23,700
-2,500
-10% -$401K 0.05% 384
2020
Q1
$2.56M Buy
26,200
+600
+2% +$58.7K 0.04% 428
2019
Q4
$3.3M Buy
25,600
+3,000
+13% +$387K 0.04% 465
2019
Q3
$1.7M Buy
+22,600
New +$1.7M 0.02% 548